Lonza wins second high-tech trial supply contract in a week
Lonza will produce clinical trial supplies of an enzyme-replacement therapy being developed by Celladon Corp as a treatment for heart failure.
Lonza will produce clinical trial supplies of an enzyme-replacement therapy being developed by Celladon Corp as a treatment for heart failure.
Dishman Pharma has followed its deal with UK drug repurposing firm Redx Pharma with plans to launch 60 generic APIs over the next two years.
The US FDA has issued draft bioequivalence guidelines for nearly 50 active pharmaceutical ingredients (API) in a notice in the Federal Register.
Quintiles has forged a deal with the Scottish Government which it says will boost clinical trial activity in the country.
WorldCare Clinical has launched a blinded independent safety and efficacy review service to speed FDA approval of clinical trial data.
Quadro Engineering says its new wet milling tech will improve API production by operating at speeds previously thought impossible.
final update
SAFC will add powder media manufacturing capabilities at its plant in Irvine in a move supported by the Scottish Government.